Review



fourier transform traction cytometry (fttc) technique  (MathWorks Inc)


Bioz Verified Symbol MathWorks Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    MathWorks Inc fourier transform traction cytometry (fttc) technique
    (A), The flowchart of isolation of hPASCs and cellular morphology. (B), ScRNA-seq analysis of hPASCs: (a), Cell types enrichment of hPASCs; (b), Markers of hPASCs; (c), KEGG enrichment of ScRNA-seq. (C), Stem cell potentiality of hPASCs: (a), Phenotype; (b), CytoTRACE; (c), Development potential by phenotype; (d), Relative order; (e), Trajectory pseudotime; (D), ECs differentiation of hPASCs: (a), Morphology of hPASCs, hUVECs and ECs differentiation of hPASCs.Scale bar 100 µm; (b), Positive control hUVECs expressing CD31 and CDH5.Scale bar 50 µm; (c), hPASCs were negative for CD31 and CDH5, Scale bar 50 µm; (d), hPASCs were positive for CD31 and CDH5 after ECs differentiation.Scale bar 50 µm. (E), Trace the cellular origins of hPASCs: (a), Cell types of placental microvessels; (b-c) correlation analysis between hPASCs and placental microvessels; (d), Predicts the original cell types of hPASCs by using the placenta microvessles data as a reference dataset. (F), Surface protein identification of hPASCs: (a) Immunofluorescence, hPASCs were positive for PAI-1 and MECOM.Scale bar 50 µm; (b) Flow <t>cytometry.</t>
    Fourier Transform Traction Cytometry (Fttc) Technique, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fourier+transform+traction+cytometry+%28fttc%29+technique/bio_rxiv__2025__07__10__664023-273-15-24?v=MathWorks+Inc
    Average 90 stars, based on 1 article reviews
    fourier transform traction cytometry (fttc) technique - by Bioz Stars, 2026-06
    90/100 stars

    Images

    1) Product Images from "Vascularized Bioengineered Kidney Using Decellularized Scaffold Recellularized with human Placenta-Derived Angiogenic stem Cells and Kidney Organoids"

    Article Title: Vascularized Bioengineered Kidney Using Decellularized Scaffold Recellularized with human Placenta-Derived Angiogenic stem Cells and Kidney Organoids

    Journal: bioRxiv

    doi: 10.1101/2025.07.10.664023

    (A), The flowchart of isolation of hPASCs and cellular morphology. (B), ScRNA-seq analysis of hPASCs: (a), Cell types enrichment of hPASCs; (b), Markers of hPASCs; (c), KEGG enrichment of ScRNA-seq. (C), Stem cell potentiality of hPASCs: (a), Phenotype; (b), CytoTRACE; (c), Development potential by phenotype; (d), Relative order; (e), Trajectory pseudotime; (D), ECs differentiation of hPASCs: (a), Morphology of hPASCs, hUVECs and ECs differentiation of hPASCs.Scale bar 100 µm; (b), Positive control hUVECs expressing CD31 and CDH5.Scale bar 50 µm; (c), hPASCs were negative for CD31 and CDH5, Scale bar 50 µm; (d), hPASCs were positive for CD31 and CDH5 after ECs differentiation.Scale bar 50 µm. (E), Trace the cellular origins of hPASCs: (a), Cell types of placental microvessels; (b-c) correlation analysis between hPASCs and placental microvessels; (d), Predicts the original cell types of hPASCs by using the placenta microvessles data as a reference dataset. (F), Surface protein identification of hPASCs: (a) Immunofluorescence, hPASCs were positive for PAI-1 and MECOM.Scale bar 50 µm; (b) Flow cytometry.
    Figure Legend Snippet: (A), The flowchart of isolation of hPASCs and cellular morphology. (B), ScRNA-seq analysis of hPASCs: (a), Cell types enrichment of hPASCs; (b), Markers of hPASCs; (c), KEGG enrichment of ScRNA-seq. (C), Stem cell potentiality of hPASCs: (a), Phenotype; (b), CytoTRACE; (c), Development potential by phenotype; (d), Relative order; (e), Trajectory pseudotime; (D), ECs differentiation of hPASCs: (a), Morphology of hPASCs, hUVECs and ECs differentiation of hPASCs.Scale bar 100 µm; (b), Positive control hUVECs expressing CD31 and CDH5.Scale bar 50 µm; (c), hPASCs were negative for CD31 and CDH5, Scale bar 50 µm; (d), hPASCs were positive for CD31 and CDH5 after ECs differentiation.Scale bar 50 µm. (E), Trace the cellular origins of hPASCs: (a), Cell types of placental microvessels; (b-c) correlation analysis between hPASCs and placental microvessels; (d), Predicts the original cell types of hPASCs by using the placenta microvessles data as a reference dataset. (F), Surface protein identification of hPASCs: (a) Immunofluorescence, hPASCs were positive for PAI-1 and MECOM.Scale bar 50 µm; (b) Flow cytometry.

    Techniques Used: Isolation, Positive Control, Expressing, Immunofluorescence, Flow Cytometry



    Similar Products

    fourier transform traction cytometry (fttc) technique  (MathWorks Inc)
    90
    MathWorks Inc fourier transform traction cytometry (fttc) technique
    (A), The flowchart of isolation of hPASCs and cellular morphology. (B), ScRNA-seq analysis of hPASCs: (a), Cell types enrichment of hPASCs; (b), Markers of hPASCs; (c), KEGG enrichment of ScRNA-seq. (C), Stem cell potentiality of hPASCs: (a), Phenotype; (b), CytoTRACE; (c), Development potential by phenotype; (d), Relative order; (e), Trajectory pseudotime; (D), ECs differentiation of hPASCs: (a), Morphology of hPASCs, hUVECs and ECs differentiation of hPASCs.Scale bar 100 µm; (b), Positive control hUVECs expressing CD31 and CDH5.Scale bar 50 µm; (c), hPASCs were negative for CD31 and CDH5, Scale bar 50 µm; (d), hPASCs were positive for CD31 and CDH5 after ECs differentiation.Scale bar 50 µm. (E), Trace the cellular origins of hPASCs: (a), Cell types of placental microvessels; (b-c) correlation analysis between hPASCs and placental microvessels; (d), Predicts the original cell types of hPASCs by using the placenta microvessles data as a reference dataset. (F), Surface protein identification of hPASCs: (a) Immunofluorescence, hPASCs were positive for PAI-1 and MECOM.Scale bar 50 µm; (b) Flow <t>cytometry.</t>
    Fourier Transform Traction Cytometry (Fttc) Technique, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fourier+transform+traction+cytometry+%28fttc%29+technique/bio_rxiv__2025__07__10__664023-273-15-24?v=MathWorks+Inc
    Average 90 stars, based on 1 article reviews
    fourier transform traction cytometry (fttc) technique - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A), The flowchart of isolation of hPASCs and cellular morphology. (B), ScRNA-seq analysis of hPASCs: (a), Cell types enrichment of hPASCs; (b), Markers of hPASCs; (c), KEGG enrichment of ScRNA-seq. (C), Stem cell potentiality of hPASCs: (a), Phenotype; (b), CytoTRACE; (c), Development potential by phenotype; (d), Relative order; (e), Trajectory pseudotime; (D), ECs differentiation of hPASCs: (a), Morphology of hPASCs, hUVECs and ECs differentiation of hPASCs.Scale bar 100 µm; (b), Positive control hUVECs expressing CD31 and CDH5.Scale bar 50 µm; (c), hPASCs were negative for CD31 and CDH5, Scale bar 50 µm; (d), hPASCs were positive for CD31 and CDH5 after ECs differentiation.Scale bar 50 µm. (E), Trace the cellular origins of hPASCs: (a), Cell types of placental microvessels; (b-c) correlation analysis between hPASCs and placental microvessels; (d), Predicts the original cell types of hPASCs by using the placenta microvessles data as a reference dataset. (F), Surface protein identification of hPASCs: (a) Immunofluorescence, hPASCs were positive for PAI-1 and MECOM.Scale bar 50 µm; (b) Flow cytometry.

    Journal: bioRxiv

    Article Title: Vascularized Bioengineered Kidney Using Decellularized Scaffold Recellularized with human Placenta-Derived Angiogenic stem Cells and Kidney Organoids

    doi: 10.1101/2025.07.10.664023

    Figure Lengend Snippet: (A), The flowchart of isolation of hPASCs and cellular morphology. (B), ScRNA-seq analysis of hPASCs: (a), Cell types enrichment of hPASCs; (b), Markers of hPASCs; (c), KEGG enrichment of ScRNA-seq. (C), Stem cell potentiality of hPASCs: (a), Phenotype; (b), CytoTRACE; (c), Development potential by phenotype; (d), Relative order; (e), Trajectory pseudotime; (D), ECs differentiation of hPASCs: (a), Morphology of hPASCs, hUVECs and ECs differentiation of hPASCs.Scale bar 100 µm; (b), Positive control hUVECs expressing CD31 and CDH5.Scale bar 50 µm; (c), hPASCs were negative for CD31 and CDH5, Scale bar 50 µm; (d), hPASCs were positive for CD31 and CDH5 after ECs differentiation.Scale bar 50 µm. (E), Trace the cellular origins of hPASCs: (a), Cell types of placental microvessels; (b-c) correlation analysis between hPASCs and placental microvessels; (d), Predicts the original cell types of hPASCs by using the placenta microvessles data as a reference dataset. (F), Surface protein identification of hPASCs: (a) Immunofluorescence, hPASCs were positive for PAI-1 and MECOM.Scale bar 50 µm; (b) Flow cytometry.

    Article Snippet: The cell traction stress field was reconstructed using the optimal filtering method based on the classic Fourier Transform Traction Cytometry (FTTC) technique, implemented in MATLAB.

    Techniques: Isolation, Positive Control, Expressing, Immunofluorescence, Flow Cytometry